Insider Stock Trading History of Casamento Charles J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Casamento Charles J since year 2005. The trader's CIK number is 1117167. At the time of this reporting, Casamento Charles J is the of Relmada Therapeutics, Inc. . (stock ticker symbol RLMD). See this page for all insider trading activities at Relmada Therapeutics, Inc. .

Note that in the past CASAMENTO CHARLES J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Casamento Charles J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-12-14 RLMD Relmada Therapeutics, Inc. Buy 4,200 2.96 12,415
2013-05-03 ASTX Supergen Inc Option Ex 71,000 2.71 192,623
2013-05-03 ASTX Supergen Inc Sale 71,000 5.89 418,190
2013-04-03 ASTX Supergen Inc Option Ex 10,000 2.01 20,099
2013-04-02 ASTX Supergen Inc Option Ex 10,000 1.98 19,800
2013-03-28 ASTX Supergen Inc Option Ex 10,000 1.98 19,800
2013-03-13 ASTX Supergen Inc Option Ex 14,000 2.46 34,440
2013-03-13 ASTX Supergen Inc Sale 14,000 4.27 59,779
2012-09-06 ASTX Supergen Inc Option Ex 50,000 2.76 138,000
2012-08-20 VVUS Vivus Inc Option Ex 8,000 5.69 45,520
2012-08-20 VVUS Vivus Inc Sale 8,000 20.63 165,064
2012-03-12 VVUS Vivus Inc Option Ex 37,000 8.77 324,601
2012-03-12 VVUS Vivus Inc Sale 37,000 20.14 745,216
2012-02-27 VVUS Vivus Inc Option Ex 36,000 6.49 233,532
2011-12-06 VVUS Vivus Inc Option Ex 25,000 4.23 105,750
2007-11-30 COR Cortex Pharmaceuticals Inc/de/ Buy 15,000 .50 7,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Casamento Charles J ( of Relmada Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.